Results 181 to 190 of about 642,036 (246)

Might retrigger with human chorionic gonadotropin be a solution for empty follicle syndrome after gonadotropin releasing hormone agonist trigger? [PDF]

Turk J Obstet Gynecol
Utkan Korun ZE, Yücetürk A, Karaosmanoğlu Ö, Çakıroğlu Y, Tıraş B.   +4 more
europepmc   +1 more source

Gonadotropin-Releasing Hormone Agonist Therapy and Longitudinal Bone Mineral Density in Congenital Adrenal Hyperplasia.

J Clin Endocrinol Metab
Flokas ME, Wakim P, Kollender S, Sinaii N, Merke DP.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis

American Journal of Obstetrics and Gynecology, 1990
Effects of danazol, gonadotropin-releasing hormone agonist (leuprolide), and danazol-leuprolide combination on experimental endometriosis were evaluated in female rats. A complete resorption of the fluid and a marked decrease in the volume of endometrium autotransplanted under the renal capsule were found after castration (1.4 +/- 0.1 mm3 in castrated,
Osamu Tanizawa, O Tanizawa, Katsuichi Sudo   +2 more
exaly   +3 more sources

Emerging gonadotropin-releasing hormone agonists

Expert Opinion on Emerging Drugs, 2011
Gonadotropin-releasing hormone agonist analogs (GnRHa) are peptides that mimic the action of gonadotropin-releasing hormone (GnRH) and are used to suppress subsequent sex steroid production. Although the analogs are a rather defined group of drugs, there have been developments in the past decades and there is still ample room for improvement.
Daniel Alexander, Beyer, Feriel, Amari, Marc, Thill, Askan, Schultze-Mosgau, Safaa, Al-Hasani, Klaus, Diedrich, Georg, Griesinger   +6 more
openaire   +2 more sources

Gonadotropin-releasing hormone agonists and the skeleton

Fertility and Sterility, 1992
To review and evaluate published studies that have assessed the effect on the skeleton of treatment with gonadotropin-releasing hormone agonists (GnRH-a). The effects on bone biochemistry and bone density are presented.Major studies reporting on bone and GnRH-a use were identified through Excerpta Medica and Medline searches.Those that have reported on
Edward E. Wallach, Ignac Fogelman
openaire   +2 more sources